showed that upregulation of the immunosuppressive glycoprotein CD200 significantly inhibited the cytolytic capacity of natural killer (NK) cells in AML patients, and that this inhibition reduced the efficiency of the immune system in the clearance of tumor cells, thereby worsening patient prognosis (48). This evidence concerns the gene CD200 and acute myeloid leukemia.